Henry J. Fuchs

Insider Reports History

Entity
Individual
Location
C/O Biomarin Pharmaceutical Inc., 105 Digital Drive, Novato, California
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Henry J. Fuchs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC President, Worldwide R&D Common Stock 196,872 $16.5 M $83.87 Mar 15, 2024 Direct
Mirati Therapeutics, Inc. Director Common Stock 10,465 $618 K $59.02 Jan 20, 2023 Direct
BIOMARIN PHARMACEUTICAL INC President, Worldwide R&D Stock Option (Right to Buy Common Stock) 40,860 Mar 15, 2024 Direct
Mirati Therapeutics, Inc. Director Non Qualified Stock Option (right to buy) 7,520 Jan 20, 2023 Direct

Insider Reports Filed by Henry J. Fuchs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2024 3 -2,808,387 4 Mar 19, 2024 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Mar 5, 2024 1 -3,010,396 4 Mar 7, 2024 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Feb 27, 2024 3 0 4 Feb 29, 2024 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Dec 1, 2023 2 21,200 4 Dec 5, 2023 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Aug 10, 2023 1 -1,085,111 4 Aug 11, 2023 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2023 4 -3,783,824 4 Mar 17, 2023 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Feb 28, 2023 3 0 4 Mar 2, 2023 President, Worldwide R&D
MRTX Mirati Therapeutics, Inc. Jan 20, 2023 2 0 4 Jan 24, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC Dec 31, 2022 1 21,281 5 Feb 10, 2023 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2022 4 -1,129,492 4 Mar 17, 2022 President, Worldwide R&D
BMRN BIOMARIN PHARMACEUTICAL INC Mar 8, 2022 1 0 4 Mar 10, 2022 President, Worldwide R&D
MRTX Mirati Therapeutics, Inc. Feb 11, 2022 7 -935,777 4 Feb 14, 2022 Director
MRTX Mirati Therapeutics, Inc. Jan 14, 2022 2 0 4 Jan 18, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC Dec 31, 2021 1 21,281 5 Feb 11, 2022 President, Worldwide R&D